Search
for
Sort by
Research 61–90 of 96
- Testosterone protects female embryonic heart H9c2 cells against severe metabolic stress by activating estrogen receptors and up-regulating IES SUR2B
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- ROS and calcium oscillations are required for polarized root hair growth
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Unsuccessful Treatment of Alopecia Areata with Simvastatin/Ezetimibe: Experience in 12 Patients
- The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
- Arabidopsis PCaP2 Functions as a Linker Between ABA and SA Signals in Plant Water Deficit Tolerance
- Gloriosa superba poisoning mimicking an acute infection- a case report
- Research progress on the natural products in the intervention of myocardial infarction
- Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis
- Advanced polymer hydrogels that promote diabetic ulcer healing: mechanisms, classifications, and medical applications
- Disease Prevention and Alleviation by Human Myoblast Transplantation
- Wnt/β-Catenin Signaling Stabilizes Hemidesmosomes in Keratinocytes
- Simvastatin-induced myoglobinuric acute kidney injury following ciclosporin treatment for alopecia universalis
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Ayurvedic management of systemic sclerosis - A case report